As healthcare decision-making becomes more patient-centric, incorporating patient perspectives is critical for developing meaningful formulary design models. New CMS regulations will require patient representation on P&T committees for plans offering essential health benefits and expand beneficiary engagement across state Medicaid agencies. But will these efforts be sufficient? Informative? If not, what practical actions are needed to ensure that the experiences of patients and beneficiaries can be translated into meaningful and actionable insights? Hear examples from experts that will support individual patients tasked with representing diverse patient populations and health conditions; pair committee membership with more representative, rigorous, and robust patient experience information; and identify policies, processes, and partnerships needed. Together, these practices can shift patient centricity from representation to informative, meaningful, and actionable guidance.